NTRB Stock Summary and Trading Ideas (Nutriband | NASDAQ:NTRB)

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Nutriband trades on the NASDAQ stock market under the symbol NTRB.

As of January 3, 2025, NTRB stock price climbed to $5.07 with 55,709 million shares trading.

NTRB has a beta of 0.45, meaning it tends to be less sensitive to market movements. NTRB has a correlation of 0.00 to the broad based SPY ETF.

NTRB has a market cap of $56.31 million. This is considered a Micro Cap stock.

In the last 3 years, NTRB traded as high as $9.60 and as low as $1.53.

The top ETF exchange traded funds that NTRB belongs to (by Net Assets): VTI, VXF.

NTRB has outperformed the market in the last year with a price return of +111.3% while the SPY ETF gained +27.8%. However, in the short term, NTRB had mixed performance relative to the market. It has underperformed in the last 3 months, returning -13.3% vs +4.6% return in SPY. But in the last 2 weeks, NTRB shares have fared better than the market returning +24.3% compared to SPY +0.1%.

NTRB support price is $4.16 and resistance is $4.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NTRB shares will trade within this expected range on the day.